E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPANCA0043(Anticancer peptide)
DFBP ID DFBPANCA0043
Peptide sequence GFSSIFRGVAKFASKGLGKDLAKLGVDLVACKISKQC
Type Native peptide
Peptide/Function name Anticancer peptide, Esculentin-2CHa
Function-activity relationship
Main bioactivity Anticancer activity
Otheir bioactivity N.D
Calculated physicochemical properties
Three-letter amino acid Gly-Phe-Ser-Ser-Ile-Phe-Arg-Gly-Val-Ala-Lys-Phe-Ala-Ser-Lys-Gly-Leu-Gly-Lys-Asp-Leu-Ala-Lys-Leu-Gly-Val-Asp-Leu-Val-Ala-Cys-Lys-Ile-Ser-Lys-Gln-Cys
Single-letter amino acid GFSSIFRGVAKFASKGLGKDLAKLGVDLVACKISKQC
Peptide length 37
Peptide mass
Experimental mass Theoretical mass
N.D 3843.57 Da c
Net charge 0.00 c
Isoelectric point (pI) 10.27 c
IC50 N.D
pIC50 N.D
GRAVY 0.3730 c
Hydrophilic residue ratio 56.76% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal, Amphibian
Organism/Source Ranidae, Chiricahua leopard frog (Lithobates chiricahuensis)
Precursor protein Skin secretions
Residue position N.D
Precursor protein(s) search
No matching precursor protein found
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
Anticancer activity

Cytotoxic activity against A549 cells.

Specific target protein(s) N.D
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Non-bitter taste prediction
SMILES NCC(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)NCC(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCCN)C(=O)NCC(=O)N[C@@]([H])(CC(C)C)C(=O)NCC(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(C)C)C(=O)NCC(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CS)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CS)C(=O)O
Preparation method
Mode of preparation

Synthesis

Enzyme(s)/starter culture

Synthesis peptide

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information N.D
Database cross-references
BIOPEP-UWM [D1] -
APD [D2] -
BioPepDB [D3] -
MBPDB [D4] -
Reference(s)
Primary literature Attoub S, Mechkarska M, Sonnevend A, Radosavljevic G, Jovanovic I, Lukic ML, Conlon JM. Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells. Peptides. 2013 Jan;39:95-102.
PMID: 23159562
Other literature(s)

[1] Wang L, Dong C, Li X, et al. Anticancer potential of bioactive peptides from animal sources (Review).[J]. Oncology Reports, 2017, 38(2).

PubDate 2013
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214